Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$536M |
| 2 |
Apple
AAPL
|
+$362M |
| 3 |
Micron Technology
MU
|
+$270M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Cisco
CSCO
|
+$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Tesla
TSLA
|
+$463M |
| 3 |
NVIDIA
NVDA
|
+$424M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Meta Platforms (Facebook)
META
|
+$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
AYTU BioPharma
AYTU
$20.6M
| $176K | ﹤0.01% |
74,723
+600
| +0.8% | +$1.41K |
|
3152
Hyperfine
HYPR
$106M
| $173K | ﹤0.01% |
159,800
+100,400
| +169% | +$108K |
|
3153
NanoViricides
NNVC
$23M
| $172K | ﹤0.01% |
114,900
+12,800
| +13% | +$19.2K |
|
3154
Idaho Strategic Resources
IDR
$426M
| $172K | ﹤0.01% |
10,700
-50,050
| -82% | -$804K |
|
3155
DocGo
DCGO
$154M
| $170K | ﹤0.01% |
+51,300
| New | +$170K |
|
3156
Achieve Life Sciences
ACHV
$161M
| $170K | ﹤0.01% |
35,860
+10,800
| +43% | +$51.2K |
|
3157
Laureate Education
LAUR
$4.28B
| $169K | ﹤0.01% |
10,200
-320,200
| -97% | -$5.32M |
|
3158
Eletrobras Preferred Shares
EBR.B
$20.4B
| $169K | ﹤0.01% |
+21,400
| New | +$169K |
|
3159
Surrozen
SRZN
$97.8M
| $166K | ﹤0.01% |
13,826
+1,400
| +11% | +$16.8K |
|
3160
Immunome
IMNM
$843M
| $165K | ﹤0.01% |
11,300
-82,000
| -88% | -$1.2M |
|
3161
Celcuity
CELC
$2.44B
| $165K | ﹤0.01% |
11,045
-40,511
| -79% | -$604K |
|
3162
Escalade
ESCA
$173M
| $164K | ﹤0.01% |
11,630
-600
| -5% | -$8.44K |
|
3163
Sky Harbour Group
SKYH
$344M
| $163K | ﹤0.01% |
+14,800
| New | +$163K |
|
3164
Forafric Global
AFRI
$227M
| $163K | ﹤0.01% |
14,400
-1,254
| -8% | -$14.2K |
|
|
AHG
3165
Akso Health Group
AHG
$1.01B
| $163K | ﹤0.01% |
152,598
-14,662
| -9% | -$15.7K |
|
3166
VYNE Therapeutics
VYNE
$8.04M
| $163K | ﹤0.01% |
86,643
+23,532
| +37% | +$44.2K |
|
|
SACH
3167
Sachem Capital Corp
SACH
$59.7M
| $161K | ﹤0.01% |
63,900
+52,300
| +451% | +$132K |
|
|
BCOW
3168
DELISTED
1895 Bancorp of Wisconsin, Inc. Common Stock
BCOW
| $161K | ﹤0.01% |
+15,900
| New | +$161K |
|
3169
Research Frontiers
REFR
$42.7M
| $160K | ﹤0.01% |
73,100
-10,700
| -13% | -$23.4K |
|
3170
One Stop Systems
OSS
$122M
| $160K | ﹤0.01% |
66,900
+5,700
| +9% | +$13.6K |
|
3171
Verastem
VSTM
$575M
| $159K | ﹤0.01% |
+53,100
| New | +$159K |
|
3172
Fractyl Health
GUTS
$72.2M
| $159K | ﹤0.01% |
62,695
+48,495
| +342% | +$123K |
|
|
VIGL
3173
DELISTED
Vigil Neuroscience
VIGL
| $156K | ﹤0.01% |
46,000
-25,500
| -36% | -$86.7K |
|
3174
Skillful Craftsman
EDTK
$17.5M
| $156K | ﹤0.01% |
136,900
-5,600
| -4% | -$6.38K |
|
|
SCNX
3175
Scienture Holdings, Inc. Common Stock
SCNX
$17.4M
| $155K | ﹤0.01% |
20,500
+8,800
| +75% | +$66.7K |
|